Takahiro Miki Selected Research

Hemoperfusion

1/2014	Effect of hemoperfusion using polymyxin B-immobilized fibers on acute lung injury in a rat sepsis model.
12/2009	Hemoperfusion with an immobilized polymyxin B fiber column decreases macrophage and monocyte activity.
12/2009	Hemoperfusion with a polymyxin B fiber column decreases clotting activity.
8/2008	Early hemoperfusion with a polymyxin b column improves gastric intramucosal pH in sepsis.
8/2008	Criteria for direct hemoperfusion with an immobilized polymyxin B fiber column based on oxygen metabolism.
10/2006	Hemoperfusion with an immobilized polymyxin B fiber column improves tissue oxygen metabolism.
10/2006	Hemoperfusion with an immobilized polymyxin B fiber column reduces circulating interleukin-8 concentrations.
8/2005	Hemoperfusion with an immobilized polymyxin B fiber column inhibits activation of vascular endothelial cells.
1/2005	Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takahiro Miki Research Topics

Disease

13	Sepsis (Septicemia) 01/2019 - 01/2005
4	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 12/2009 - 10/2006
4	Infections 12/2009 - 10/2006
3	Low Back Pain (Lumbago) 05/2022 - 01/2017
2	Inflammation (Inflammations) 01/2019 - 01/2015
2	Septic Shock (Toxic Shock Syndrome) 01/2014 - 08/2008
2	Acute Lung Injury 01/2014 - 01/2005
2	Hyperalgesia 10/2012 - 06/2011
2	Cystitis 10/2012 - 06/2011
2	Pain (Aches) 10/2012 - 06/2011
1	Kinesiophobia 01/2020
1	Death (Near-Death Experience) 01/2019
1	Liver Failure 01/2019
1	Renal Insufficiency (Renal Failure) 01/2019
1	AIDS-Related Complex (ARC) 01/2016
1	Atrophy 02/2015
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 06/2011
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2005

Drug/Important Bio-Agent (IBA)

8	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2014 - 01/2005
4	CatecholaminesIBA 12/2009 - 10/2006
3	LipopolysaccharidesIBA 07/2014 - 12/2009
3	Oxygen (Dioxygen)IBA 08/2008 - 08/2005
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2015
2	Histones (Histone)IBA 01/2015 - 07/2014
2	ThrombomodulinIBA 07/2014 - 04/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2012 - 06/2011
1	HaptoglobinsIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	SiliconIBA 01/2019
1	Ceruloplasmin (Ferroxidase)IBA 01/2019
1	ZincIBA 01/2016
1	Pharmaceutical PreparationsIBA 02/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2015
1	Phenolsulfonphthalein (Phenol Red)IBA 02/2015
1	Interleukin-6 (Interleukin 6)IBA 01/2015
1	ProcalcitoninIBA 01/2015
1	AntithrombinsIBA 07/2014
1	DNA (Deoxyribonucleic Acid)IBA 07/2014
1	LyasesIBA 10/2012
1	CystathionineIBA 10/2012
1	Proteins (Proteins, Gene)FDA Link 10/2012
1	Cysteine (L-Cysteine)FDA Link 10/2012
1	MibefradilIBA 10/2012
1	NNC 55-0396IBA 10/2012
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2012
1	EnzymesIBA 10/2012
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2011
1	Dinoprostone (PGE2)FDA Link 06/2011
1	ProstaglandinsIBA 06/2011
1	Plasminogen Activator Inhibitor 1IBA 12/2009
1	Interleukin-8 (Interleukin 8)IBA 10/2006

Therapy/Procedure

9	Hemoperfusion 01/2014 - 01/2005
2	Therapeutics 05/2022 - 04/2014
2	Intravenous Infusions 07/2014 - 04/2014
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2020
1	Orthotic Devices (Orthosis) 01/2017
1	Parenteral Nutrition 02/2015
1	Early Goal-Directed Therapy 08/2008